Australia, Sept. 22 -- Filamon Ltd., owns the trademark (2626447) for 'KESONOTIDE' till Feb. 11, 2036.
Status: registered:
Registered/protected
Class: 5 [Pharmaceutical preparations; pharmaceutical preparations for the treatment of cancer; anti-cancer pharmaceutical preparations; compounds for treating cancer; pharmaceutical preparations for the treatment of cardiovascular conditions; pharmaceutical preparations for the treatment of autoimmune conditions; pharmaceutical preparations for the treatment of inflammatory conditions; pharmaceutical preparations for the treatment of fibrotic diseases; pharmaceutical preparations for the treatment of viral infections; pharmaceutical preparations for the treatment of metabolic conditions; topical ...